Related Experiment Video
Updated: May 16, 2025
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.1K
Does Midbrain Atrophy Distinguish Progressive Supranuclear Palsy from Frontotemporal Dementia?
Mauro César Quintão E Silva Cunningham1,2, Sarah Teixeira Camargos1,3,4, Vinícius Ribeiro Jeunon2
1Ambulatório de Distúrbios de Movimento, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Movement Disorders Clinical Practice
|April 2, 2025
Summary
Midbrain atrophy measures offer moderate accuracy in differentiating progressive supranuclear palsy (PSP) from behavioral variant frontotemporal dementia (bvFTD). Specific metrics like midbrain area and brainstem volume showed the highest diagnostic potential in this study.
Area of Science:
- Neuroimaging
- Neurology
- Dementia Research
Background:
- Distinguishing between behavioral variant frontotemporal dementia (bvFTD) and progressive supranuclear palsy (PSP) is diagnostically challenging.
- The role of midbrain atrophy in differentiating these conditions remains unclear.
Purpose of the Study:
- To evaluate the diagnostic value of midbrain atrophy measures in differentiating PSP from bvFTD.
- To compare quantitative and qualitative atrophy metrics between patient groups and healthy controls.
Main Methods:
- Included four groups: healthy controls, PSP, bvFTD, and Parkinson's disease (PD).
- Assessed midbrain atrophy using the Hummingbird sign rating scale (HBS-RS), global midbrain atrophy (GMA), midbrain area, midbrain/pons ratio, Magnetic Resonance Parkinsonism Index (MRPI) 2.0, and brainstem volume.
Main Results:
- PSP and bvFTD groups exhibited reduced midbrain area, HBS-RS, and GMA compared to controls.
- Several measures, including midbrain area (83%) and brainstem volume (82%), demonstrated modest accuracy in distinguishing PSP from bvFTD.
Conclusions:
- Both quantitative and qualitative midbrain atrophy assessments provide moderate accuracy for differentiating PSP from bvFTD.
- These findings contribute to understanding neuroimaging markers for differential diagnosis in neurodegenerative diseases.
Related Concept Videos
01:15Parkinson's Disease: Overview
353
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
353
01:37Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
01:26Alzheimer's Disease: Overview
350
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
350
01:30Dementia
76
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
76
01:24Prosopagnosia
113
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
113